40 likes | 164 Views
Figure 1. A. SKOV-3, 48h. Viable cells (%). SW 43. SW 43. SW 43. ○ ● ■ □. ○ ● ■ □. ○ ● ■ □. SW IV-52s. SW IV-52s. SW IV-52s. SW III-123. SW III-123. SW III-123. SW 43 + SW IV-52s. SW 43 + SW IV-52s. SW 43 + SW IV-52s. Concentration (µM). B. CaOV-3, 48h.
E N D
Figure 1 A SKOV-3, 48h Viable cells (%) SW 43 SW 43 SW 43 ○ ● ■ □ ○ ● ■ □ ○ ● ■ □ SW IV-52s SW IV-52s SW IV-52s SW III-123 SW III-123 SW III-123 SW 43 + SW IV-52s SW 43 + SW IV-52s SW 43 + SW IV-52s Concentration (µM) B CaOV-3, 48h Viable cells (%) Concentration (µM) C BG-1, 48h Viable cells (%) Concentration (µM)
Figure 2 5 min SW III-123 (M) 0 1 3 10 Phospho NF-B p65 NF-B p65 Actin
Figure 3 CaOV-3 cells A - TNF Ab Caspase 3 activity (fold) + TNF Ab SW IV-52s SW 43 SW III-123 B SW 43 Viable cells (%) SW 43 + TNF Ab SW 43 (µM) C Viable cells (%) SW IV-52s SW IV-52s + TNF Ab SW IV-52s (µM) D Viable cells (%) SW III-123 SW III-123 + TNF Ab SW III-123 (µM)
Figure 4 BG-1 cells A B Viable cells (%) SW 43 SW 43 + TNF Ab Caspase 3 activity (fold) - TNF Ab + TNF Ab SW 43 (µM) C SW IV-52s SW 43 SW III-123 Viable cells (%) SW IV-52s SW IV-52s + TNF Ab SW IV-52s (µM) D Viable cells (%) SW III-123 SW III-123 + TNF Ab SW III-123 (µM)